Acrivastine and pseudoephedrine and Insulin degludec and liraglutide Subcutaneous
Determining the interaction of Acrivastine and pseudoephedrine and Insulin degludec and liraglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acrivastine / pseudoephedrine
Brand name: Semprex-D
Synonyms: Acrivastine and Pseudoephedrine
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acrivastine and pseudoephedrine-Insulin degludec Subcutaneous
- Acrivastine and pseudoephedrine-Insulin detemir
- Acrivastine and pseudoephedrine-Insulin Detemir (Cartridges and Prefilled Syringes)
- Acrivastine and pseudoephedrine-Insulin Detemir (Vials)
- Acrivastine and pseudoephedrine-Insulin detemir Subcutaneous
- Acrivastine and pseudoephedrine-Insulin glargine
- Insulin degludec and liraglutide Subcutaneous-Actamin
- Insulin degludec and liraglutide Subcutaneous-Actamin Maximum Strength
- Insulin degludec and liraglutide Subcutaneous-Actemra
- Insulin degludec and liraglutide Subcutaneous-Actemra (Tocilizumab (Intravenous))
- Insulin degludec and liraglutide Subcutaneous-Actemra (Tocilizumab Auto-Injectors)
- Insulin degludec and liraglutide Subcutaneous-Actemra (Tocilizumab Prefilled Syringes)